79202821 - VECTURA

Information

• Trademark
• 79202821

• Source

• Serial Number

  79202821

• Registration Number

  5337619

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  November 25, 2016
  7 years ago

• Registration Date

  November 21, 2017
  7 years ago

• Transaction Date

  July 16, 2024
  4 months ago

• Status Date

  June 07, 2024
  5 months ago

• Published for Opposition Date

  September 05, 2017
  7 years ago

• Location Date

  November 21, 2017
  7 years ago

• Status Code

  709

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  BLANDU, FLORENTINA

• Attorney Docket Number

  AJO2-304-TM

  Attorney Name

  Molly B. Markley

  Law Office Assigned Location Code

  M80

• Owners

  • Vectura GmbH

Case File Statements

• DM0000: The mark consists of a letter "V" made up of 6 oblique lines and a small triangle. The upper right corner of the "V" is blue and the lower left corner is blue. The mark also features the word "VECTURA" in blue. The background of the mark is white.
• CD0000: Green upper right corner of "V" device; blue lower left corner of "V" device; blue wording.
• GS0051: Pharmaceutical and biological preparations for medical purpose, namely for the treatment of diseases or conditions of the respiratory system; pharmaceutical and biological preparations for medical purposes, namely the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and biological preparations for medical purposes, namely for the alleviation or prevention of pain or inflammation; pharmaceutical and biological preparations for medical purposes, namely, powders for asthma inhalers; pharmaceutical and biological preparations for medical purposes, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genitourinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purpose, namely, medicaments for inhalation therapy; pharmaceutical and biological preparations for medical purposes, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; pharmaceutical and biological preparations for medical purpose, namely medicaments for the treatment of erectile dysfunction, medicaments for the treatment of chronic obstructive pulmonary disease, medicaments for the treatment of premature ejaculation, medicaments for the treatment of cystic fibrosis, medicaments for the treatment of female sexual dysfunction, medicaments for the treatment of migraines, and medicaments for the treatment of asthma
• CC0000: The color(s) blue, green, and white is/are claimed as a feature of the mark.
• GS0101: Drug delivery devices, namely, drug delivery systems; inhalers for medical use; metered dose inhalers for medical use; active dry powder inhalers for medical use; passive dry powder inhalers for medical use; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods
• GS0421: Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing namely device and product testing of drug delivery devices and medical preparations

Case File Event Statements

• 3/9/2017 - 7 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 3/10/2017 - 7 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/11/2017 - 7 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 3/14/2017 - 7 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 3/15/2017 - 7 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/16/2017 - 7 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 3/16/2017 - 7 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 3/16/2017 - 7 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 4/2/2017 - 7 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 7/20/2017 - 7 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/20/2017 - 7 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/21/2017 - 7 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/16/2017 - 7 years ago

  14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/5/2017 - 7 years ago

  15 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/5/2017 - 7 years ago

  16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/21/2017 - 7 years ago

  17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 2/21/2018 - 6 years ago

  18 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 3/2/2018 - 6 years ago

  19 - FINAL DISPOSITION PROCESSED Type: FIMP

• 3/3/2018 - 6 years ago

  20 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 4/27/2018 - 6 years ago

  21 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 7/23/2017 - 7 years ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/21/2022 - 2 years ago

  23 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 12/22/2023 - 11 months ago

  24 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 6/7/2024 - 5 months ago

  25 - CANCELLED SECTION 71 Type: C71T

• 10/8/2022 - 2 years ago

  22 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP